{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:22:27Z","timestamp":1788733347189,"version":"build-2803163510"},"reference-count":130,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Sturge\u2013Weber syndrome (SWS) is a rare congenital neurovascular disorder that initially presents with a facial port-wine birthmark (PWB) and most commonly associated with a R183Q somatic mosaic mutation in the gene <jats:italic>GNAQ<\/jats:italic>. This mutation is enriched in endothelial cells. Contrast-enhanced magnetic resonance imaging (MRI) diagnoses brain abnormalities including leptomeningeal vascular malformation, an enlarged choroid plexus, and abnormal cortical and subcortical blood vessels. Mouse SWS models identify dysregulated proteins important for abnormal vasculogenesis and blood brain barrier permeability. Recent clinical research has focused on early diagnosis, biomarker development, presymptomatic treatment, and development of novel treatment strategies. Prospective pilot clinical drug trials with cannabidiol (Epidiolex) or with sirolimus, an mTOR inhibitor, indicate possible reductions in seizure frequency and improved cognitive outcome. This review connects the most recent molecular research in SWS cell culture and animal models to developing new treatment methods and identifies future areas of research.<\/jats:p>","DOI":"10.3389\/fneur.2024.1493873","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T05:10:25Z","timestamp":1733116225000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Sturge\u2013Weber syndrome: updates in translational neurology"],"prefix":"10.3389","volume":"15","author":[{"given":"Chase","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/B978-0-444-52899-5.00046-0","article-title":"Neurocutaneous syndromes","volume":"108","author":"Kurlemann","year":"2012","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/IIO.0b013e318259df76","article-title":"Neuro-ophthalmic features of the neurocutaneous syndromes","volume":"52","author":"Chan","year":"2012","journal-title":"Int Ophthalmol Clin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/IIO.0b013e31823bbb7a","article-title":"Retinal manifestations of the phakomatoses","volume":"52","author":"Haug","year":"2012","journal-title":"Int Ophthalmol Clin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/13816810.2020.1731834","article-title":"Incidence of Sturge-weber syndrome and associated ocular involvement in Olmsted County, Minnesota, United States","volume":"41","author":"Rihani","year":"2020","journal-title":"Ophthalmic Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajo.2022.11.009","article-title":"Incidence of Sturge-weber syndrome and risk of secondary Glaucoma: a Nationwide population-based study using a rare disease registry","volume":"247","author":"Ha","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"77e","DOI":"10.1097\/PRS.0000000000001868","article-title":"Endothelial cells from capillary malformations are enriched for somatic GNAQ mutations","volume":"137","author":"Couto","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2016.10.010","article-title":"Somatic GNAQ mutation is enriched in brain endothelial cells in Sturge-weber syndrome","volume":"67","author":"Huang","year":"2017","journal-title":"Pediatr Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e40439","DOI":"10.1371\/journal.pone.0040439","article-title":"Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype","volume":"7","author":"Ho","year":"2012","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3390\/ijms20092243","article-title":"The pathogenesis of port wine stain and Sturge weber syndrome: complex interactions between genetic alterations and aberrant MAPK and PI3K activation","volume":"20","author":"Nguyen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1358863X18786068","article-title":"G\u03b1q and hyper-phosphorylated ERK expression in Sturge-weber syndrome leptomeningeal blood vessel endothelial cells","volume":"24","author":"Wellman","year":"2019","journal-title":"Vasc Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/bjophthalmol-2020-317287","article-title":"Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-weber syndrome","volume":"106","author":"Wu","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e046","DOI":"10.1097\/JOVA.0000000000000046","article-title":"Phosphorylated-S6 expression in Sturge-weber syndrome brain tissue","volume":"3","author":"McCann","year":"2022","journal-title":"J Vasc Anom"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1203\/01.PDR.0000058921.54071.19","article-title":"Increased fibronectin expression in sturge-weber syndrome fibroblasts and brain tissue","volume":"53","author":"Comi","year":"2003","journal-title":"Pediatr Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jaad.2015.09.063","article-title":"The somatic GNAQ mutation (R183Q) is primarily located within the blood vessels of port wine stains","volume":"74","author":"Tan","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.otohns.2008.07.015","article-title":"The expression of vascular endothelial growth factor and its receptors in port-wine stains","volume":"139","author":"Vural","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref17","first-page":"48","article-title":"Facial port-wine stains and Sturge-weber syndrome","volume":"76","author":"Enjolras","year":"1985","journal-title":"Pediatrics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpeds.2017.05.053","article-title":"Size of facial port-wine birthmark may predict neurologic outcome in Sturge-weber syndrome","volume":"188","author":"Dymerska","year":"2017","journal-title":"J Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2014.11.009","article-title":"A prospective study of risk for Sturge-weber syndrome in children with upper facial port-wine stain","volume":"72","author":"Dutkiewicz","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1542\/peds.87.3.323","article-title":"Location of port-wine stains and the likelihood of ophthalmic and\/or central nervous system complications","volume":"87","author":"Tallman","year":"1991","journal-title":"Pediatrics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jaapos.2009.04.007","article-title":"Port-wine vascular malformations and glaucoma risk in Sturge-weber syndrome","volume":"13","author":"Sharan","year":"2009","journal-title":"J AAPOS"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/NRL.0b013e318220c5b6","article-title":"Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-weber syndrome","volume":"17","author":"Comi","year":"2011","journal-title":"Neurologist"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aos.15808","article-title":"The use of benzalkonium chloride in topical glaucoma treatment: an investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells","volume":"101","author":"Nagstrup","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"108620","DOI":"10.1016\/j.exer.2021.108620","article-title":"Modeling the effects of glaucoma surgery on intraocular pressure","volume":"209","author":"Farrar","year":"2021","journal-title":"Exp Eye Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"100879","DOI":"10.1016\/j.preteyeres.2020.100879","article-title":"Personalising surgical treatments for glaucoma patients","volume":"81","author":"Sunaric Megevand","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41433-018-0024-4","article-title":"Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-weber syndrome","volume":"32","author":"Randon","year":"2018","journal-title":"Eye (Lond)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/088307389501000113","article-title":"Sturge-weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children","volume":"10","author":"Sujansky","year":"1995","journal-title":"J Child Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/088307388800300306","article-title":"Prognosis in Sturge-weber disease: comparison of Unihemispheric and Bihemispheric involvement","volume":"3","author":"Bebin","year":"1988","journal-title":"J Child Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000120677","article-title":"The natural history of patients with the Sturge-weber syndrome","volume":"18","author":"Oakes","year":"1992","journal-title":"Pediatr Neurosurg"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pediatrneurol.2006.08.006","article-title":"Myoclonic-astatic epilepsy in a child with Sturge-weber syndrome","volume":"36","author":"Ewen","year":"2007","journal-title":"Pediatr Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00381-008-0705-6","article-title":"Infantile spasms in the setting of Sturge-weber syndrome","volume":"25","author":"Barbagallo","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/08830738050200080901","article-title":"Comorbidity of epilepsy and headache in patients with Sturge-weber syndrome","volume":"20","author":"Kossoff","year":"2005","journal-title":"J Child Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/088307389801301204","article-title":"Central nervous system structure and function in Sturge-weber syndrome: evidence of neurologic and radiologic progression","volume":"13","author":"Maria","year":"1998","journal-title":"J Child Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11940-013-0253-6","article-title":"Sturge-weber syndrome","volume":"15","author":"Bachur","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00431-024-05448-z","article-title":"Neurological function and drug-refractory epilepsy in Sturge-weber syndrome children: a retrospective analysis","volume":"183","author":"Zhang","year":"2024","journal-title":"Eur J Pediatr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"120766","DOI":"10.1016\/j.jns.2023.120766","article-title":"Drug-resistant epilepsy: definition, pathophysiology, and management","volume":"452","author":"Mesraoua","year":"2023","journal-title":"J Neurol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2329048X221129678","DOI":"10.1177\/2329048X221129678","article-title":"Spontaneous resolution of drug-resistant epilepsy in patients with Sturge-weber syndrome","volume":"9","author":"Alawadhi","year":"2022","journal-title":"Child Neurol Open"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/s0190-9622(87)80249-9","article-title":"Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin","volume":"16","author":"Happle","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106161","DOI":"10.1016\/j.eplepsyres.2019.106161","article-title":"Somatic mutation: the hidden genetics of brain malformations and focal epilepsies","volume":"155","author":"Ye","year":"2019","journal-title":"Epilepsy Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1074\/jbc.M411709200","article-title":"Role of protein phosphatase 2A in mGluR5-regulated MEK\/ERK phosphorylation in neurons","volume":"280","author":"Mao","year":"2005","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e3000866","DOI":"10.1371\/journal.pbio.3000866","article-title":"Histamine-induced biphasic activation of RhoA allows for persistent RhoA signaling","volume":"18","author":"Zhang","year":"2020","journal-title":"PLoS Biol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"eadf2173","DOI":"10.1126\/scisignal.adf2173","article-title":"Unraveling allostery within the angiotensin II type 1 receptor for G\u03b1q and \u03b2-arrestin coupling","volume":"16","author":"Cao","year":"2023","journal-title":"Sci Signal"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/mol.113.086322","article-title":"Arginine vasopressin enhances cell survival via a G protein-coupled receptor kinase 2\/\u03b2-arrestin1\/extracellular-regulated kinase 1\/2-dependent pathway in H9c2 cells","volume":"84","author":"Zhu","year":"2013","journal-title":"Mol Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jid.2020.03.978","article-title":"Identification of a mosaic activating mutation in GNA11 in atypical Sturge-weber syndrome","volume":"141","author":"Thorpe","year":"2021","journal-title":"J Invest Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1111\/ene.15452","article-title":"GNA11-mutated Sturge-weber syndrome has distinct neurological and dermatological features","volume":"29","author":"Dompmartin","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jid.2023.09.008","article-title":"GNAQ\/GNA11 mosaicism is associated with abnormal serum calcium indices and microvascular Neurocalcification","volume":"144","author":"Kn\u00f6pfel","year":"2024","journal-title":"J Invest Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/hmg\/ddab144","article-title":"A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-weber syndrome","volume":"30","author":"Fj\u00e6r","year":"2021","journal-title":"Hum Mol Genet"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ajmg.a.63106","article-title":"Genetic testing in the evaluation of individuals with clinical diagnosis of atypical Sturge-weber syndrome","volume":"191","author":"Yeom","year":"2023","journal-title":"Am J Med Genet A"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/jmedgenet-2019-106024","article-title":"RASA1 mosaic mutations in patients with capillary malformation-arteriovenous malformation","volume":"57","author":"Revencu","year":"2020","journal-title":"J Med Genet"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/pde.15443","article-title":"Spectrum of lymphatic anomalies in patients with RASA1-related CM-AVM","volume":"40","author":"Mologousis","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1158\/0008-5472.CAN-14-3229","article-title":"Oncogenic G protein GNAQ induces uveal melanoma and Intravasation in mice","volume":"75","author":"Huang","year":"2015","journal-title":"Cancer Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10456-022-09841-w","article-title":"A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis","volume":"25","author":"Galeffi","year":"2022","journal-title":"Angiogenesis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41467-023-37516-7","article-title":"MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ","volume":"14","author":"Schrenk","year":"2023","journal-title":"Nat Commun"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"iyad077","DOI":"10.1093\/genetics\/iyad077","article-title":"Developmental expression of the Sturge-weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis","volume":"224","author":"Wetzel-Strong","year":"2023","journal-title":"Genetics"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e099","DOI":"10.1097\/JOVA.000000000000009","article-title":"R183Q GNAQ Sturge-weber syndrome leptomeningeal and cerebrovascular developmental mouse model","volume":"5","author":"Solomon","year":"2024","journal-title":"J Vasc Anom"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jmgm.2017.07.011","article-title":"Computational analysis for GNAQ mutations: new insights on the molecular etiology of Sturge-weber syndrome","volume":"76","author":"Martins","year":"2017","journal-title":"J Mol Graph Model"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e172842","DOI":"10.1172\/JCI172842","article-title":"Capillary malformations","volume":"134","author":"Hammill","year":"2024","journal-title":"J Clin Invest"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.clineuro.2012.02.030","article-title":"Melanocytic tumor with GNA11 p.Q209L mutation mimicking a foramen magnum meningioma","volume":"114","author":"Strom","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2018.01.081","article-title":"GNA11 Q209L mouse model reveals RasGRP3 as an essential signaling node in uveal melanoma","volume":"22","author":"Moore","year":"2018","journal-title":"Cell Rep"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/pcmr.12843","article-title":"GNAQQ209L expression initiated in multipotent neural crest cells drives aggressive melanoma of the central nervous system","volume":"33","author":"Urtatiz","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamaophthalmol.2018.5141","article-title":"Association of Somatic GNAQ mutation with capillary malformations in a case of choroidal hemangioma","volume":"137","author":"Bichsel","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.4103\/ijo.IJO_1840_18","article-title":"Retinal vascular abnormalities in Sturge-weber syndrome","volume":"67","author":"Ratra","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1161\/ATVBAHA.121.316651","article-title":"Endothelial GNAQ p.R183Q increases ANGPT2 (Angiopoietin-2) and drives formation of enlarged blood vessels","volume":"42","author":"Huang","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-024-01757-4","article-title":"MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge weber syndrome","volume":"12","author":"Nasim","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s43018-023-00710-z","article-title":"INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas","volume":"5","author":"Elbatsh","year":"2024","journal-title":"Nat Cancer"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jid.2023.08.028","article-title":"GNAQ\/GNA11 mosaicism causes aberrant calcium signaling susceptible to targeted therapeutics","volume":"144","author":"Zecchin","year":"2024","journal-title":"J Invest Dermatol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/modpathol.3800995","article-title":"Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy","volume":"21","author":"Iwenofu","year":"2008","journal-title":"Mod Pathol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"H693","DOI":"10.1152\/ajpheart.00570.2017","article-title":"Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment","volume":"314","author":"van Skike","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3892\/ijmm.2021.5011","article-title":"Selenium attenuates ischemia\/reperfusion injury-induced damage to the blood-brain barrier in hyperglycemia through PI3K\/AKT\/mTOR pathway-mediated autophagy inhibition","volume":"48","author":"Yang","year":"2021","journal-title":"Int J Mol Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"16106","DOI":"10.1038\/ncomms16106","article-title":"Pericyte-expressed Tie2 controls angiogenesis and vessel maturation","volume":"8","author":"Teichert","year":"2017","journal-title":"Nat Commun"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-016-1551-3","article-title":"Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling","volume":"131","author":"Gurnik","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/01.STR.0000170712.46106.2e","article-title":"Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain","volume":"36","author":"Zhu","year":"2005","journal-title":"Stroke"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00381-014-2573-6","article-title":"Preliminary reliability and validity of a battery for assessing functional skills in children with Sturge-weber syndrome","volume":"30","author":"Reidy","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.braindev.2024.05.001","article-title":"Variation in neuroimaging and outcomes in patients with Sturge weber syndrome type III","volume":"46","author":"Hadjinicolaou","year":"2024","journal-title":"Brain and Development"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.eplepsyres.2014.01.023","article-title":"EEG evolution in Sturge-Weber syndrome","volume":"108","author":"Kossoff","year":"2014","journal-title":"Epilepsy Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2021.02.006","article-title":"Multicenter research data of epilepsy Management in Patients with Sturge-Weber Syndrome","volume":"119","author":"Smegal","year":"2021","journal-title":"Pediatr Neurol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pediatrneurol.2019.04.004","article-title":"Quality of life in children with Sturge-weber syndrome","volume":"101","author":"Harmon","year":"2019","journal-title":"Pediatr Neurol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2020.03.013","article-title":"Suicide screening in Sturge-weber syndrome: an important issue in need of further study","volume":"110","author":"Sebold","year":"2020","journal-title":"Pediatr Neurol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2022.08.009","article-title":"Multicenter assessment of Sturge-weber syndrome: a retrospective study of variations in care and use of natural history data","volume":"138","author":"Arnesen","year":"2023","journal-title":"Pediatr Neurol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge-weber syndrome: side effects and clinical outcomes","volume":"28","author":"Lance","year":"2013","journal-title":"J Child Neurol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/pde.13841","article-title":"Preventive treatment with oral sirolimus and aspirin in a newborn with severe Sturge-weber syndrome","volume":"36","author":"Triana Junco","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00381-008-0662-0","article-title":"Subgaleal hematoma in a child with Sturge-weber syndrome: to prevent stroke-like episodes, is treatment with aspirin advisable?","volume":"24","author":"Greco","year":"2008","journal-title":"Childs Nerv Syst"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejpn.2020.05.001","article-title":"Headache in children with Sturge-weber syndrome \u2013 prevalence, associations and impact","volume":"27","author":"Arkush","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1817-1745.131483","article-title":"Paroxysmal vascular events in Sturge-weber syndrome: role of aspirin","volume":"9","author":"Sanghvi","year":"2014","journal-title":"J Pediatr Neurosci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2018.04.009","article-title":"Hypothesis: Presymptomatic treatment of Sturge-weber syndrome with aspirin and antiepileptic drugs may delay seizure onset","volume":"90","author":"Day","year":"2019","journal-title":"Pediatr Neurol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/acn3.546","article-title":"Deep cerebral vein expansion with metabolic and neurocognitive recovery in Sturge-weber syndrome","volume":"5","author":"John","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/B978-0-444-52891-9.00037-3","article-title":"Sturge-Weber syndrome","volume":"111","author":"Nabbout","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/dmcn.14253","article-title":"Early magnetic resonance imaging to detect presymptomatic leptomeningeal angioma in children with suspected Sturge-weber syndrome","volume":"62","author":"Bar","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejpn.2022.04.002","article-title":"Early MRI diagnosis of Sturge weber syndrome type 1 in infants","volume":"38","author":"Catsman-Berrevoets","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/TACG.S363685","article-title":"Sturge-weber syndrome: a review of pathophysiology, genetics, clinical features, and current management Approache","volume":"16","author":"S\u00e1nchez-Espino","year":"2023","journal-title":"Appl Clin Genet"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jocn.2012.02.048","article-title":"Fast-brain MRI in children is quick, without sedation, and radiation-free, but beware of limitations","volume":"20","author":"Rozovsky","year":"2013","journal-title":"J Clin Neurosci"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/jmri.26703","article-title":"Techniques for minimizing sedation in pediatric MRI","volume":"50","author":"Dong","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/cns3.20058","article-title":"Retrospective analysis of Presymptomatic treatment in Sturge-weber syndrome","volume":"2","author":"Valery","year":"2024","journal-title":"Ann Child Neurol Soc"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/seiz.2001.0629","article-title":"Prophylactic antiepileptic treatment in Sturge-weber disease","volume":"11","author":"Ville","year":"2002","journal-title":"Seizure"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/lrb.2007.1012","article-title":"Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo","volume":"5","author":"Shirazi","year":"2007","journal-title":"Lymphat Res Biol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCRESAHA.119.315185","article-title":"Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation","volume":"126","author":"Boada","year":"2020","journal-title":"Circ Res"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol Rev"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40257-020-00528-w","article-title":"New and emerging targeted therapies for vascular malformations","volume":"21","author":"Van Damme","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/s0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI119382","article-title":"Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells","volume":"99","author":"Javier","year":"1997","journal-title":"J Clin Invest"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/aob\/mcq243","article-title":"Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation","volume":"107","author":"Strzalka","year":"2011","journal-title":"Ann Bot"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1161\/STROKEAHA.123.044108","article-title":"mTORC1 inhibitor rapamycin inhibits growth of cerebral cavernous malformation in adult mice","volume":"54","author":"Li","year":"2023","journal-title":"Stroke"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3109\/00207454.2012.721827","article-title":"Rapamycin preconditioning attenuates transient focal cerebral ischemia\/reperfusion injury in mice","volume":"122","author":"Yin","year":"2012","journal-title":"Int J Neurosci"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J Neurosci"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jaad.2014.10.011","article-title":"Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial","volume":"72","author":"Marqu\u00e9s","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pediatrneurol.2020.10.013","article-title":"Sirolimus Treatment in Sturge-Weber Syndrome","volume":"115","author":"Sebold","year":"2021","journal-title":"Pediatr Neurol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/SCS.0000000000007034","article-title":"Sirolimus as a potential treatment for Sturge-weber syndrome","volume":"32","author":"Sun","year":"2021","journal-title":"J Craniofac Surg"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/pde.14520","article-title":"Facial hemihypertrophy in a girl with sturge-weber syndrome: treatment with oral sirolimus","volume":"38","author":"Giacaman","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamaophthalmol.2024.0854","article-title":"Oral Sirolimus for diffuse choroidal hemangioma in Sturge-weber syndrome","volume":"142","author":"Kalantary","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/biom14091190","article-title":"Therapeutic approaches to tuberous sclerosis complex: from available therapies to promising drug targets","volume":"14","author":"Conte","year":"2024","journal-title":"Biomol Ther"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"e173095","DOI":"10.1172\/jci.insight.173095","article-title":"Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations","volume":"8","author":"Seront","year":"2023","journal-title":"JCI Insight"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-030-57369-0_7","article-title":"Cannabidiol therapy for refractory epilepsy and seizure disorders","volume":"1264","author":"Golub","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/j.expneurol.2022.114238","article-title":"Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: a systematic review and meta-analysis","volume":"359","author":"Talwar","year":"2023","journal-title":"Exp Neurol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.irn.2024.03.009","article-title":"Cannabidiol and epilepsy","volume":"177","author":"Moreira","year":"2024","journal-title":"Int Rev Neurobiol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.33696\/neurol.2.040","article-title":"Combined Antiseizure efficacy of Cannabidiol and clonazepam in a conditional mouse model of Dravet syndrome","volume":"2","author":"Chuang","year":"2021","journal-title":"J Exp Neurol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","article-title":"GPR55: a therapeutic target for Parkinson's disease?","volume":"125","author":"Celorrio","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.3390\/molecules25215186","article-title":"Molecular targets of Cannabidiol in experimental models of neurological disease","volume":"25","author":"Silvestro","year":"2020","journal-title":"Molecules"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s11064-017-2287-8","article-title":"Evaluation of Cannabidiol in animal seizure models by the epilepsy therapy screening program (ETSP)","volume":"42","author":"Klein","year":"2017","journal-title":"Neurochem Res"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/molecules28062805","article-title":"The potential mechanism of Cannabidiol (CBD) treatment of epilepsy in Pentetrazol (PTZ) kindling mice uncovered by multi-omics analysis","volume":"28","author":"Lu","year":"2023","journal-title":"Molecules"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"815950","DOI":"10.3389\/fphar.2022.815950","article-title":"Cannabidiol increases seizure resistance and improves behavior in an Scn8a mouse model","volume":"13","author":"Shapiro","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"11286","DOI":"10.1038\/s41598-022-15134-5","article-title":"Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures","volume":"12","author":"Dearborn","year":"2022","journal-title":"Sci Rep"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.06.010","article-title":"Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-induced seizures and neurogenesis","volume":"500","author":"Victor","year":"2022","journal-title":"Neuroscience"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"114294","DOI":"10.1016\/j.expneurol.2022.114294","article-title":"Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy","volume":"360","author":"Golub","year":"2023","journal-title":"Exp Neurol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"109245","DOI":"10.1016\/j.yebeh.2023.109245","article-title":"Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures","volume":"143","author":"Caraballo","year":"2023","journal-title":"Epilepsy Behav"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.02.009","article-title":"Cannabidiol treatment for refractory seizures in Sturge-weber syndrome","volume":"71","author":"Kaplan","year":"2017","journal-title":"Pediatr Neurol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2022.10.014","article-title":"Cannabidiol treatment for neurological, cognitive, and psychiatric symptoms in Sturge-weber syndrome","volume":"139","author":"Smegal","year":"2023","journal-title":"Pediatr Neurol"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/epi.14477","article-title":"Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: expanded access program results","volume":"59","author":"Szaflarski","year":"2018","journal-title":"Epilepsia"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1493873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T05:10:32Z","timestamp":1733116232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1493873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":130,"alternative-id":["10.3389\/fneur.2024.1493873"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1493873","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"article-number":"1493873"}}